The recent instability in global chains have highlighted the value of securing vital medications like Ivermectin. Dependence on overseas vendors exposes countries to considerable vulnerabilities, including delivery delays, expense fluctuations, and even geopolitical threats. Moving towards domestic procurement of Ivermectin offers a multitude of ad